Search Results
Results 101 - 150 of 776
1 2 3 4 5 6 7 8 9 10 >
Meyers, P; ;
The implementation of the Choice on Termination of Pregnancy Act, Act No. 92 of 1996 brought many challenges for the registered nurses/midwife assisting in the termination of pregnancy. In the gynaecological wards at a tertiary level hospital, registered nurses/midwives assist with the termination of pregnancies for women in the second ...
Pye Seonaid M - - 2008
Imatinib has now been in use for almost 10 years. Despite this cumulative experience, little is known about its effects on pregnancy; as a result, there are few published data to facilitate the counseling of women who conceive while taking imatinib. The results we now present provide information which may ...
Prasad Sudha - - 2009
OBJECTIVES: To assess the efficacy, safety, and acceptability of early termination of pregnancy by vaginal administration of a single dose of misoprostol. SETTING: Healthy women seeking abortion in an institutional research environment in a tertiary-care hospital. DESIGN: Prospective randomized controlled clinical trial. PARTICIPANTS: One hundred forty women seeking termination of ...
Lawton Beverley A - - 2008
BACKGROUND: Sexually transmitted infections increase the risk of postoperative complications after termination of pregnancy. Mycoplasma genitalium is sexually transmitted and associated with adverse clinical outcomes in both males and females. The prevalence of M. genitalium is not yet known in New Zealand women or among women presenting for termination of ...
Pasquini L - - 2008
We report our experience with intracardiac administration of potassium chloride as safe and effective method for late termination of pregnancy (TOP) and to document the indications for feticide in a major tertiary unit. During the study period (January 2000 and December 2005), 239 late terminations of pregnancy were performed at ...
Fawole Adeniran O - - 2008
BACKGROUND: Although supported by research evidence, misoprostol for induction of labour remains contentious. OBJECTIVE: To assess perception and practice of obstetricians regarding use of misoprostol for labour induction. METHODOLOGY: Cross-sectional questionnaire-based survey of Senior Registrars and Consultant Obstetricians in southwestern Nigeria. RESULTS: One hundred and six questionnaires were completed (52.8% ...
Chen Beatrice A - - 2008
Misoprostol use in early pregnancy may incur a risk of uterine rupture in women with previous uterine surgery. We analyzed 488 women who received misoprostol 800 microg vaginally in a study that evaluated medical and surgical management of early pregnancy failure. Subjects received a repeat misoprostol dose if expulsion was ...
Saxena Pikee - - 2008
OBJECTIVE: To compare efficacy of sublingual (S/L), oral and vaginal routes of misoprostol administration for cervical priming before suction evacuation (SE) under local anaesthesia. METHODS: In a prospective randomised clinical trial, 200 women in the first trimester of pregnancy were randomised into four groups of 50 each. Patients in control ...
Papiernik E E Université Paris V Réné Descartes et Maternité de Port-Royal, Assistance-Publique Hôpitaux, Paris, - - 2008
To study the impact of terminations of pregnancy (TOP) on very preterm mortality in Europe. European prospective population-based cohort study. Ten regions from nine European countries participating in the MOSAIC (Models of OrganiSing Access to Intensive Care for very preterm babies) study. These regions had different policies on screening for ...
Grapsas X - - 2008
OBJECTIVE: To investigate the efficacy of vaginal administration of 800 microg misoprostol as a single dose without performing post expulsion systematic curettage in first trimester pregnancy termination. METHOD: 113 women, aged 16-44, who requested first trimester pregnancy termination, received 800 microg of vaginal misoprostol. All examined women were divided into ...
Billiet Kelly - - 2008
BACKGROUND: Because seminal prostaglandins play a role at natural fertilization, it was hypothesized that vaginal supplementation of prostaglandins at the time of intrauterine insemination (IUI) might enhance chances of conception. We investigated the effect of misoprostol, a prostaglandin analogue, on the success rate of IUI. METHODS: A multi-center double-blind randomized ...
Silva Luciana Vivas - - 2008
OBJECTIVES: To compare the general characteristics and clinical outcome of women who underwent medical termination of pregnancy preceded or not by feticide. METHODS: A total of 146 women of diverse gestational ages, who had received a sonographic or genetic diagnosis of fetal abnormality incompatible with postnatal life and chose to ...
Reeves Matthew F - - 2008
We sought to compare endometrial thickness after misoprostol or dilation and curettage (D&C) for early pregnancy failure and to assess the predictive value of endometrial thickness for subsequent D&C after misoprostol treatment. In a randomized trial of early pregnancy failure management, 491 women were treated with misoprostol vaginally, and 161 ...
Gilleard Wendy - - 2008
Rising to stand from a chair becomes more difficult to perform as pregnancy progresses, which may lead to altered biomechanics affecting the musculoskeletal demands on the body segments. The kinematic and kinetic adaptations in the lower limbs and trunk as pregnancy progresses are unknown. Nine maternal subjects were investigated using ...
Patel Ashlesha - - 2008
BACKGROUND: In our public hospital, first-trimester pregnancy termination historically had been performed in an operating room by suction curettage on a separate day following the initial clinic visit. To increase efficiency, we instituted three changes over a 2-year period: (a) pregnancy termination procedures were relocated to the outpatient area; (b) ...
Ho Vincent - - 2007
Misoprostol is a synthetic prostaglandin analog administered vaginally to induce labor for intrauterine death or termination of pregnancy for congenital abnormalities. We encountered a case of misoprostol induction of labor at 14 weeks of gestation for fetal acrania associated with amniotic bands. Histology demonstrated abundant deposits of refractile material appearing ...
Edwards Scott - - 2007
OBJECTIVE: To compare the safety, efficacy, postprocedure quality of life, and acceptability of manual vacuum aspiration (MVA) performed as an outpatient with electric vacuum aspiration (EVA) performed in a hospital in women experiencing a first-trimester miscarriage. METHODS: From a randomized multicenter trial comparing misoprostol with vacuum aspiration for first-trimester loss, ...
Carbonell Josep L - - 2008
BACKGROUND: This study was conducted to compare efficacy and safety of 600 mcg of misoprostol vaginally every 6 h up to four doses vs. 400 mcg of misoprostol vaginally every 4 h up to five doses, followed by systematic curettage of the uterine cavity, for pregnancy termination between 12 and ...
Ho P C - - 2007
A combination of mifepristone and misoprostol is the regimen of choice for termination of pregnancy between 13 to 26 weeks. In many countries, mifepristone is still not available, and misoprostol has to be used alone. Many misoprostol-alone regimens have been reported in the literature with apparently good results. Most of ...
Faúndes A - - 2007
The aim was to review the current knowledge about the use of misoprostol alone for abortion induction during the first 12 weeks of pregnancy. Publications reporting experiences with misoprostol alone for pregnancy termination within the first 12 weeks of pregnancy were included in the analysis. Vaginal administration of 800 microg ...
Noble Ray - - 2008
Fetal therapy raises ethical concerns in relation to the balance of potential benefit and harm, autonomy and informed consent, and the duties of the clinician to the pregnant women and fetus. Invasive therapy should be recommended only when it has a realistic chance of saving the life of the fetus ...
Shwekerela B - - 2007
OBJECTIVE: To investigate the safety, efficacy, and acceptability of misoprostol versus manual vacuum aspiration (MVA) for treatment of incomplete abortion. DESIGN: A prospective open-label randomised trial. SETTING: Kagera Regional Hospital, Bukoba, Tanzania. SAMPLE: Three hundred women with a clinical diagnosis of incomplete abortion and a uterine size <12 weeks. METHODS: ...
Morris Kirsty - - 2007
The aim of the present review was to explore the role of the psychiatrist in late terminations of pregnancy. A literature review was conducted using MEDLINE and psycINFO databases, focussing on articles that explored (i) existing decision-making processes in late terminations; (ii) psychological sequelae of both early and late termination ...
Cheung Grace W Y - - 2007
BACKGROUND: Embedded fetal bone after surgical termination of midtrimester pregnancy is a recognized complication. Most cases occur in the uterine cavity; however, this case demonstrates that a cervicovaginal fistula can be caused by embedment of bone in the cervical canal. CASE: A 19-year-old girl presented with persistent smelly vaginal discharge ...
Ustunyurt Emin - - 2008
INTRODUCTION: The aim of this study was to evaluate the criteria of endometrial thickness to detect retained products of conception following first trimester spontaneous abortion or elective pregnancy termination. METHODS: This was a retrospective study on 116 patients who underwent uterine re-evacuation with a diagnosis of retained products of conception ...
Daponte A - - 2007
We set out to evaluate the safety and efficacy of the proposed misoprostol regimen in women with previous multiple caesarean sections. This was a retrospective cohort study of 21 women with more than one caesarean section who underwent termination of pregnancy (TOP) with 400 mug of vaginal misoprostol followed by ...
Denguezli Walid - - 2007
OBJECTIVE: To compare the efficacy and safety of intravaginal misoprostol versus dinoprostone cervical gel for cervical ripening and labour induction. METHODS: We carried out an experimental clinical trial in which we enrolled 130 cervical consecutive patients with cervical ripening, randomly assigned to one of the following two treatment groups: (1) ...
Sherer D M - - 2007
We report a case in which a patient presented with severe right lower abdominal pain associated with nausea and vomiting 3 days after termination of pregnancy. Transvaginal ultrasonography showed a large intramural mass in the anterior aspect of the lower segment of an acutely retroflexed uterus. Computed tomography and magnetic ...
Rahman Talha A - - 2007
Laws that regulate the identification of a foetus and the termination of a pregnancy in India are shaped by their social context. The Medical Termination of Pregnancy Act, 1971, discriminates against unmarried women by not recognising that unwanted pregnancies in unmarried women could result in at least as much anguish ...
van Bogaert L-J - - 2007
A total of 273 women underwent termination of pregnancy (TOP) with a single regimen of misoprostol (400 microg orally and 800 microg vaginally), without mifepristone. A total of 98 (35.9%) were first trimester and 175 (64.1%) second trimester gestations. Of these women, 189 (69.2%) responded to a single administration of ...
Robledo C - - 2007
To identify clinical indicators for success of misoprostol treatment after early pregnancy failure. A total of 473 women with early pregnancy failure received 800 microg of vaginal misoprostol on treatment day 1. At the follow-up visit on day 3, a second dose was given if expulsion was incomplete. On day ...
Khazardoost Soghra S Perinatalogy Department, Vali-e-Asr Reproductive Health Research Centre, Tehran University of Medical Sciences, Tehran, Iran. - - 2007
The purpose of this study was to compare the efficacy and side-effects of two regimens of vaginal misoprostol for pregnancy termination of up to 16 weeks. A randomised clinical trial of medical pregnancy termination of up to 16 weeks was conducted. A hundred pregnant women requesting legal termination of pregnancy ...
Abdul, M. A.
Background: Misoprostol – a prostaglandin E1 analogue is effective in the induction of labour in the 2nd and 3rd trimester pregnancies. There is paucity of information in the use of misoprostol for labour induction in our setting. Method: Non-randomized clinical trial. Results: Thirty-four consecutive patients with real time ultrasonographically confirmed ...
Nuttall Coral-Kay - - 2007
In general terms, healthcare professionals are not at liberty to refuse to care for any patient (UKCC 2004). However, as the law permits patients to do what is morally and ethically right for them with regard to termination of pregnancy, it must also extend this right to the healthcare professional. ...
Yilmaz Bulent - - 2007
OBJECTIVE: The aim of this randomized prospective study was to compare efficacy and side effects of saline moistened misoprostol with dry misoprostol, administered 800 mug intravaginally every 6 h up to a maximum of 3 doses in 24 h for second trimester pregnancy termination. MATERIALS AND METHODS: A total of ...
Aygören-Pürsün E - - 2007
Without treatment, pregnancies in patients with congenital afibrinogenemia terminate in miscarriage at 5-6 weeks of gestation. Animal model studies have suggested that implantation site bleeding contributes to miscarriage in afibrinogenemia; however, retrochorionic hematoma in human congenital afibrinogenemia has not been previously observed. A patient with congenital afibrinogenemia receiving fibrinogen prophylaxis ...
Custer Edward E - - 2007
The objective of this study was to develop a method that could reliably determine the arginine vasopressin (AVP) and/or oxytocin (OT) content of individual rat neurohypophysial terminals (NHT) >or=5 microm in diameter, the size used for electrophysiological recordings. We used a commercially available, highly sensitive enzyme-linked immunoassay (ELISA) kit with ...
Wyldes M P - - 2007
Terminations of pregnancy for fetal anomaly (TOPFAs) were analysed over a 10-year period from a population-based congenital anomaly register covering 646,342 births. A total of 3189 cases of TOPFA were identified, prevalence of 49.3 per 10,000 registerable births. The rate of TOPFA at all gestations and at less than 16 ...
Naz Sobia - - 2007
OBJECTIVE: To assess efficacy, safety and cost effectiveness of misoprostol (prostaglandin E1 analogue) for termination of pregnancy. METHODS: A descriptive study was conducted from March 2003 to December 2004, at Fauji Foundation Hospital Rawalpindi. A total of 200 patients, at 10-28 weeks of gestation, requiring termination of pregnancy were included. ...
Marinoni E - - 2007
OBJECTIVE: To investigate the effectiveness and complication rate of intravaginal gemeprost, a prostaglandin E(1) analogue, for second-trimester pregnancy termination in women with a scarred uterus. METHODS: Of 439 women undergoing induced abortion between the 13th and the 23rd week of pregnancy, 67 had a scarred uterus because of 1 or ...
Givens Vanessa M - - 2007
BACKGROUND: Extrusion of fetal parts into the abdomen after second-trimester pregnancy termination is rare. CASE: We report a case of extrusion of fetal parts into the broad ligament at the time of second-trimester pregnancy termination that remained undetected for 10 days. CONCLUSION: In cases of perforation during second-trimester pregnancy termination, ...
Bhattacharjee Nabendu - - 2007
OBJECTIVE: To evaluate the efficacy and safety of PGE1 analogue, misoprostol, for inducing abortion or labour during mid-trimester in women who have had a prior Caesarean section (one or more). STUDY DESIGN: Women who had to undergo termination of pregnancy between 13 and 26 weeks of gestation for various indications ...
Korenromp Marijke J - - 2007
OBJECTIVE: This study explores decisional processes regarding termination of pregnancy because of Down syndrome and aims to identify possibilities for improving counseling. STUDY DESIGN: Seventy-one women completed questionnaires 4 months after termination of pregnancy for Down syndrome, including motivations for the decision, reasons for doubt, perceived influence and/or pressure at ...
Guest J - - 2007
OBJECTIVE: To determine the efficacy of oral mifepristone followed by vaginal misoprostol 6 hours later compared with the standard 36- to 48-hour regimen for medical termination of pregnancy. DESIGN: Single centre, two arm, parallel, open randomised controlled trial. SETTING: Medical termination service at a teaching hospital. SAMPLE: Four hundred and ...
Burkart Thomas A - - 2007
Sustained atrial fibrillation and atrial flutter during pregnancy are uncommon arrhythmias that can significantly complicate normal prenatal care. Direct current external cardioversion is the current method of terminating these arrhythmias. In practice, however, this technique is sometimes considered undesirable by both physician and patients due to the need for deep ...
Carbonell Josep Lluis - - 2007
OBJECTIVES: The study was conducted to assess the effectiveness of mifepristone 200 mg 48 h before administering misoprostol 600 mug, sublingual vs. vaginal route, prior to dilation and evacuation (D&E) in 12- to 20-week pregnancies. DESIGN: Randomized clinical trial. SETTING: Clínica Mediterrania Médica, Valencia, Spain. SUBJECTS: Women with 12- to ...
M. Khooshideh
To assess the effectiveness of prostaglandin E1 analog, misoprostol, compared with a prostaglandin E2 analog, dinoprostone in termination of pregnancies in second trimester complicated by intrauterine fetal death. This clinical trial was performed on 40 pregnant women between 15 and 28 weeks which were terminated due to intrauterine fetal demise. ...
Nilas Lisbeth - - 2007
METHODS: A retrospective 2-year cohort study of 127 women, with gestation between 13 and 24 weeks and a live fetus, seeking induced abortion. The aim was to compare the effect of a 1-day and a 2-day interval between oral mifepristone (200 mg) and vaginal misoprostol (400 microg) every 3 h. ...
Doggrell Sheila A - - 2007
Nearly 20% of all pregnancies end in early pregnancy failure, and surgical evacuation of retained products of conception is often used to manage this failure. Misoprostol is an inexpensive, stable analog of prostaglandin E(1), and is powerful at contracting the uterus. With intravaginal misoprostol, the peak plasma levels are lower, ...
Alsulaiman Ayman - - 2007
OBJECTIVE: To assess the attitudes of Saudi parents towards prenatal diagnosis and termination of pregnancy for a range of different genetic disorders. METHODS: Two hundred Saudi parents (100 fathers and 100 mothers) completed a structured questionnaire which sought their views about each of 30 different conditions. RESULTS: The great majority ...
1 2 3 4 5 6 7 8 9 10 >